Log in to save to my catalogue

A novel haemocytometric COVID-19 prognostic score developed and validated in an observational multic...

A novel haemocytometric COVID-19 prognostic score developed and validated in an observational multic...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d0f18f38e8b44385bc7777229cacf794

A novel haemocytometric COVID-19 prognostic score developed and validated in an observational multicentre European hospital-based study

About this item

Full title

A novel haemocytometric COVID-19 prognostic score developed and validated in an observational multicentre European hospital-based study

Publisher

England: eLife Sciences Publications, Ltd

Journal title

eLife, 2020-11, Vol.9

Language

English

Formats

Publication information

Publisher

England: eLife Sciences Publications, Ltd

More information

Scope and Contents

Contents

COVID-19 induces haemocytometric changes. Complete blood count changes, including new cell activation parameters, from 982 confirmed COVID-19 adult patients from 11 European hospitals were retrospectively analysed for distinctive patterns based on age, gender, clinical severity, symptom duration, and hospital days. The observed haemocytometric patt...

Alternative Titles

Full title

A novel haemocytometric COVID-19 prognostic score developed and validated in an observational multicentre European hospital-based study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d0f18f38e8b44385bc7777229cacf794

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d0f18f38e8b44385bc7777229cacf794

Other Identifiers

ISSN

2050-084X

E-ISSN

2050-084X

DOI

10.7554/eLife.63195

How to access this item